Key result
Anxiety and depression symptoms demonstrated significant bi-directional negative associations with health-related quality of life over a 3-month period in adult patients with diabetes.
Why the study?
Little is known about how anxiety and depression symptoms and health-related quality of life over time influence each other in patients with diabetes.
How do anxiety and depression symptoms and health-related quality of life (HRQoL) influence each other over time in patients with diabetes?
Observational (n=131)
No
How do anxiety and depression symptoms and health-related quality of life (HRQoL) influence each other over time in patients with diabetes?
p-value: p=<0.05
There is a bi-directional relationship between anxiety/depression and health-related quality of life in patients with diabetes over time, supporting the need for early detection and comprehensive management.
May warrant mental health screening in diabetes; leaves open whether treating symptoms improves HRQoL.
Anxiety and depression are commonly found in patients with diabetes, but little is known about how the anxiety and depression symptoms of diabetes patients and the health-related quality of life (HRQoL) over time influence each other. Therefore, we conducted a survey among patients with diabetes (T1) and repeated the survey after 3 months (T2). Linear regression models and cross-lagged structural equation models were used to analyze the associations between anxiety and depression symptoms and HRQoL within and across time intervals. Correcting for baseline index and potential confounders, the HRQoL index at T2 reflected the change in anxiety/depression between T1 and T2 more than anxiety/depression at T1 ( P < 0.05). Similarly, anxiety and depression at T2 reflected the change in the EQ-5D index over time more than the index at baseline ( P < 0.05). Our longitudinal data fitted well in a cross-lagged model with bi-directional pathways of associations between anxiety and HRQoL, as well as depression and HRQoL, among adult patients with diabetes (x 2 /df = 1.102, P = 0.256; CFI = 1.000, RMSEA = 0.030). Our findings support early detection of anxiety and depression, as well as comprehensive efforts improving HRQoL for patients with diabetes.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2020) conducted an observational in Type 1 or Type 2 diabetes (n=131). Anxiety and depression symptoms vs. Baseline status was evaluated on Longitudinal association between anxiety/depression and HRQoL (EQ-5D summary index) (p=<0.05). Anxiety and depression symptoms demonstrated significant bi-directional negative associations with health-related quality of life over a 3-month period in adult patients with diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: